Contact Congress about H.R. 5768: Skin Substitute Access and Payment Reform Act

Medicare would cover skin substitute products under one clearer payment system starting in 2026. The highest-paid providers would face extra claim checks and prior approval rules.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Skin Substitute Access and Payment Reform Act is a House bill in committee. The latest recorded action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Latest action on H.R. 5768: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Who this affects: This bill mainly affects Medicare patients who need skin substitute products for wounds, the providers who use and bill for them, and the companies that make them. Patients could see more regular Medicare coverage, but reviews tied to some providers could affect timing. Providers with very high Medicare payments would face the most direct oversight. Medicare would also change how it pays, tracks, and reviews these products.

Why this matters: Medicare payment rules can shape which wound products patients get and how much providers are paid. This bill would make payment more uniform, but that may help some products and hurt others. It could also help Medicare spot improper billing by focusing on the highest-paid providers. The tradeoff is that extra reviews and prior approval can add delays and paperwork.

Key provisions in H.R. 5768

• The bill defines which wound products count as skin substitute products. They must be certain cellular, tissue, biological, or synthetic materials placed on a wound and meant to stay there. Temporary dressings and liquids, gels, or powders do not count.
• Medicare Part B would cover skin substitute products. Part B is the part of Medicare that helps pay for many doctor and outpatient services.
• A new Medicare payment method would start on January 1, 2026. It would use section 1847A, the Medicare law section used for some drugs and biological products.
• Medicare would set the 2026 payment amount using 2023 data. The formula would weigh 2023 Medicare payment limits by how much each product was used in 2023 claims.
• After 2026, Medicare would update payments each year for inflation. The update would use the Consumer Price Index for All Urban Consumers, or CPI-U.

How Modern Action helps you take action on H.R. 5768

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about H.R. 5768

What is H.R. 5768?

Medicare would cover skin substitute products under one clearer payment system starting in 2026. The highest-paid providers would face extra claim checks and prior approval rules.

How do I support or oppose H.R. 5768?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about H.R. 5768?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

Can Modern Action explain H.R. 5768 before I act?

Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.